scispace - formally typeset
Y

Yao Lu

Researcher at Vaccine and Infectious Disease Organization

Publications -  11
Citations -  212

Yao Lu is an academic researcher from Vaccine and Infectious Disease Organization. The author has contributed to research in topics: Virus & Influenza A virus subtype H5N1. The author has an hindex of 5, co-authored 11 publications receiving 107 citations. Previous affiliations of Yao Lu include Western University College of Veterinary Medicine & University of Saskatchewan.

Papers
More filters
Journal ArticleDOI

Nuclear-resident RIG-I senses viral replication inducing antiviral immunity

TL;DR: The authors identify nuclear RIG-I and show that it binds nuclear influenza A virus RNA, resulting in a cooperative interferon induction along with its cytoplasmic counterpart, refine the RNA sensing paradigm for nuclear-replicating viruses and reveal a previously unrecognized subcellular milieu for Rig-I-like receptor sensing.
Journal ArticleDOI

The NS1 Protein of Influenza A Virus Participates in Necroptosis by Interacting with MLKL and Increasing Its Oligomerization and Membrane Translocation.

TL;DR: It is reported that influenza A virus (IAV) infection induces necroptosis in macrophages and epithelial cells and it is demonstrated that the NS1 protein of IAV interacts with MLKL, resulting in increasedMLKL oligomerization and membrane translocation.
Journal ArticleDOI

Inhibition of Ongoing Influenza A Virus Replication Reveals Different Mechanisms of RIG-I Activation.

TL;DR: RIG-I activation in response to NP deprivation is not adversely affected by expression of the nuclear export protein (NEP), which diminishes the generation of a major subset of aberrant viral RNA but facilitates the accumulation of small viral RNA (svRNA).
Journal ArticleDOI

In Vivo Characterization of Avian Influenza A (H5N1) and (H7N9) Viruses Isolated from Canadian Travelers.

TL;DR: This study characterized the pathogenicity of AB14 (H5N1) and BC15 (H7N9) and found that both strain isolates are highly lethal in mice, providing experimental evidence to complement the specific human case reports and animal models for evaluating vaccine and antiviral candidates against potential influenza pandemics.